Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of “Buy” by Analysts
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been given a consensus rating of “Buy” by the nine brokerages that are currently covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target […]
More Stories
SPDR Portfolio Long Term Treasury ETF (NYSEARCA:SPTL) Hits New 1-Year Low – Time to Sell?
SPDR Portfolio Long Term Treasury ETF (NYSEARCA:SPTL – Get Free Report)’s stock price hit a new 52-week low on Tuesday...
Reviewing KKR Real Estate Finance Trust (NYSE:KREF) & BrightSpire Capital (NYSE:BRSP)
KKR Real Estate Finance Trust (NYSE:KREF – Get Free Report) and BrightSpire Capital (NYSE:BRSP – Get Free Report) are both...
Ultrapar Participações (NYSE:UGP) Shares Gap Up – What’s Next?
Ultrapar Participações S.A. (NYSE:UGP – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had...
ASE Technology (NYSE:ASX) Shares Gap Up – Time to Buy?
ASE Technology Holding Co., Ltd. (NYSE:ASX – Get Free Report)’s stock price gapped up prior to trading on Tuesday ....
ProShares Ultra Silver (NYSEARCA:AGQ) Shares Gap Up – Still a Buy?
Shares of ProShares Ultra Silver (NYSEARCA:AGQ – Get Free Report) gapped up prior to trading on Tuesday . The stock...
Union Pacific (NYSE:UNP) Price Target Cut to $265.00 by Analysts at Wells Fargo & Company
Union Pacific (NYSE:UNP – Get Free Report) had its price objective lowered by analysts at Wells Fargo & Company from...